Dr. Green is the director of the National Human Genome Research Institute, one of the 27 institutes and centers that make up the U.S. National Institutes of Health, the federal agency that funds and conducts medical research. The NIH Intramural Sequencing Center is a lab that Dr. Green founded and which is part of the National Human Genome Research Institute.
Prior to this appointment, he was the Scientific Director of NHGRI, a position he held since 2002. In addition, Green serves as chief of the NHGRI Genome Technology Branch (since 1996) and director of the NIH Intramural Sequencing Center (NISC) (since 1997).
Now we’re starting to see how genome research is fulfilling the promise of why we pursued the Human Genome Project in the first place.
As genomics becomes relevant to medical care, regulatory agencies like the FDA are going to be watching this and making sure it’s being done properly.
Eric Green: I predict, starting over the next few years, women will opt to just simply give a little bit of blood which they’re giving anyway as part of their clinical care.
The switch to next generation DNA sequencing has drastically reduced the price of human genome sequencing over the past decade from near a billion dollars to just a few thousand.